GeneDx Holdings (WGS) EBITDA Margin (2020 - 2026)
GeneDx Holdings (WGS) posted quarterly EBITDA Margin of 56.2% for Q1 2026, down 5098.0% year-over-year from 1.12% in Q1 2025, and down 377.7% quarter-over-quarter from 11.77% in Q4 2025.
GeneDx Holdings (WGS) EBITDA Margin (2020 - 2026) Analysis & Trends
GeneDx Holdings (WGS) has reported EBITDA Margin for 7 consecutive years, with 56.2% the latest figure, recorded in Q1 2026.
- In Q1 2026, EBITDA Margin fell 5098.0% year-over-year to 56.2%; the TTM figure through Mar 2026 stood at 14.91% (down 1064.0% YoY), while the FY2025 annual figure was 3.06%, up 454.0% from the prior year.
- EBITDA Margin declined to 56.2% in Q1 2026 per WGS's latest filing, from 11.77% in the prior quarter.
- Across five years, EBITDA Margin topped out at 9.21% in Q4 2024 and bottomed at 529.56% in Q4 2022.
- Historically, EBITDA Margin has averaged 101.77% across 5 years, with a median of 44.66% in 2023.
- Annual changes were most pronounced in 2022 — EBITDA Margin sank 35302 bps — and 2023, when it surged 48489 bps.
- GeneDx Holdings' EBITDA Margin stood at 529.56% in 2022, then jumped by 92 bps to 44.66% in 2023, then soared by 121 bps to 9.21% in 2024, then sank by 228 bps to 11.77% in 2025, then tumbled by 378 bps to 56.2% in 2026.
- Business Quant data shows WGS's EBITDA Margin at 56.2% in Q1 2026, 11.77% in Q4 2025, and 2.78% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 17.40% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 17.99% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -10.07% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 21.74% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 11.58% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 34.98% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 21.14% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 31.97% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 12.10% |
| 10 | GeneDx Holdings | 2.65 Bn | 2.52 Bn | 78.24 Mn | -15.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -15.25% |
| Mar 31, 2026 | -56.20% |
| Dec 31, 2025 | -11.77% |
| Sep 30, 2025 | -2.78% |
| Jun 30, 2025 | 8.73% |
| Mar 31, 2025 | -5.22% |
| Dec 31, 2024 | 9.21% |
| Sep 30, 2024 | -10.12% |
| Jun 30, 2024 | -15.00% |
| Mar 31, 2024 | -21.88% |
| Dec 31, 2023 | -44.66% |
| Sep 30, 2023 | -80.61% |
| Jun 30, 2023 | -105.99% |
| Mar 31, 2023 | -139.93% |
| Dec 31, 2022 | -529.56% |
| Sep 30, 2022 | -109.11% |
| Jun 30, 2022 | -449.69% |
| Mar 31, 2022 | -165.56% |
| Dec 31, 2021 | -200.31% |
| Sep 30, 2021 | -204.42% |